American College of Clinical Pharmacy
      Search      Cart


Washington Report: Updates in Therapeutics® 2018 - Patient-Centered Team-Based Practice Forum

Accelerating the Adoption and Sustainability of Comprehensive Medication Management

Written by John K. McGlew
Director of Government Affairs


ACCP is pleased to announce an important new educational program in conjunction with the annual Updates in Therapeutics® Preparatory Review and Recertification Courses: the Patient-Centered Team-Based Practice Forum - Accelerating the Adoption and Sustainability of Comprehensive Medication Management.

In 2018, for the first time, ACCP will offer this multifaceted, workshop-style event that immerses ambulatory care practitioners in the foundational elements of comprehensive medication management (CMM) and prepares them for initial or continued implementation of CMM services.

The forum, to be held February 16-18, 2018 at the Hyatt Regency Jacksonville Riverfront Hotel in Florida, will provide attendees with a first look at the tools, strategies, and lessons learned from ACCP's Implementation and Effectiveness of CMM in Primary Care study. In addition, the event will guide participants on how to drive the adoption and expansion of CMM within their home organizations and help them establish an initial action plan designed to put implementation efforts on a path that will achieve the defined aim.

The forum will be moderated by Todd Sorensen, Pharm.D., FCCP, and Mary Roth McClurg, Pharm.D., MHS, FCCP, the principal investigators for ACCP's CMM grant. The event will also feature a keynote presentation from policy leaders at the Centers for Medicare & Medicaid Services (CMS) and - consistent with the broader focus on team-based care - representatives from the family medicine community.

More information about this important forum can be found here, or by e-mailing Dan Aistrope at

ACCP Statement to the CMS Related to a New Direction for the CMS Innovation Center

On September 20, 2017, CMS announced an informal Request for Information (RFI) seeking feedback on a new direction for the Center for Medicare & Medicaid Innovation ("Innovation Center") to promote patient-centered care and test market-driven reforms that empower beneficiaries as consumers, provide price transparency, and increase choices and competition to drive quality, reduce costs, and improve outcomes.

The Innovation Center was established in 2010 under the Affordable Care Act to test "innovative payment and service delivery models to reduce program expenditures...while preserving or enhancing the quality of care" for individuals who receive Medicare, Medicaid, or Children's Health Insurance Program (CHIP) benefits. Since then, the Innovation Center has played a critical role in implementing the Quality Payment Program, created as part of the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) to pay for physicians' and other providers' services.

The CMS RFI called for stakeholder input on eight key focus areas:

  • Increased participation in Advanced Alternative Payment Models (APMs)
  • Consumer-Directed Care and Market-Based Innovation Models
  • Physician Specialty Models
  • Prescription Drug Models
  • Medicare Advantage (MA) Innovation Models
  • State-Based and Local Innovation, including Medicaid-Focused Models
  • Mental and Behavioral Health Models and
  • Program Integrity.

In response to the RFI, ACCP submitted comments to CMS calling for inclusion of CMM practices and programs that optimize the use of medications by America's seniors, as part of the process of evaluating the future of the Innovation Center and its role in promoting patient-centered care and shifting Medicare payment policy for providers toward value of care and away from volume of services.

ACCP's comments highlighted the fact that although CMM services are increasingly available in MA plans as part of its efforts to drive innovation, improve quality and outcomes, and lower costs, Medicare's current benefit structure lacks a team-based and patient-centered medication management service for the vast majority of beneficiaries. The comments also drew attention to the important work currently under way as part of ACCP's CMM Effectiveness and Implementation Grant.

This outreach to CMS and the announcement of ACCP's Patient-Centered Team-Based Practice Forum in Jacksonville, Florida, are just two examples of the College's ongoing efforts to explore legislative and regulatory opportunities to secure the integration of CMM services within evolving Medicare APMs to help ensure medication optimization, enhance patient safety, promote value-based rather than volume-based care to patients, and contribute to greater affordability and sustainability for the Medicare program.

Click here to view ACCP's comments to CMS in full.

For more information on any of ACCP's advocacy efforts, please contact:

John K. McGlew
Director, Government Affairs
American College of Clinical Pharmacy
1455 Pennsylvania Ave. Northwest
Suite 400
Washington, DC 20004-1017
(202) 621-1820